The Schall Law Firm is investigating potential breaches of fiduciary duty by Olo Inc.'s directors and management related to its acquisition by Thoma Bravo for $10.25 per share.

Olo reported Q2 2025 revenue of $85.7 million, exceeding expectations, and announced a $2.0 billion acquisition by Thoma Bravo at $10.25 per share, representing a 65% premium to its prior unaffected share price.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers and acquisitions.

Olo Inc. is under investigation by a securities law firm for potential breaches of fiduciary duties in its pending $2 billion all-cash acquisition by Thoma Bravo at $10.25 per share.

Replimune Group faces a class action lawsuit after receiving a Complete Response Letter from the FDA regarding its RP1 melanoma treatment, with stock price dropping over 75% due to concerns about clinical trial design and effectiveness.